Emotionally Unstable Personality Disorder (EUPD), also referred to as Borderline Personality Disorder (BPD), impacts social interactions, mood stability, and may lead to impulsive or self-harming actions. The cost of treatment can be high, with success rates between 35% and 50%. Researchers are investigating alternative treatments to complement the traditional therapies available at Get Kush Canada.
A notable addition to EUPD treatment is cannabis, commonly known as weed. It’s budget-friendly, and its components can offer benefits to patients with EUPD. Individuals who find multiple treatments unaffordable might look into cheap cannabis online options at Get Kush Canada for more economical choices.
Table of Contents
Key Takeaways:
- Participants with EUPD using THC or high CBD report positive results in symptom management.
- High doses of CBD (800 mg/day) and THC flower treatment can elevate circulating levels of anandamide.
- Dysfunction in the endocannabinoid system, which manages emotions and stress, plays a role in Emotionally Unstable Personality Disorder.
Understanding EUPD or BPD
EUPD is a mental health disorder that affects self-perception and interpersonal relationships, causing challenges in day-to-day life. It is characterized by intense, unstable relationships, impulsivity, and an altered self-image.
While the precise causes remain unknown, genetics, trauma, and neurotransmitter imbalances might contribute. Issues in the endocannabinoid system responsible for regulating emotions and stress may be linked to EUPD symptoms.
Treatment Options for EUPD
Although guidelines indicate no medications are definitively effective for EUPD, clinicians still prescribe drugs like antipsychotics and antidepressants.
Antipsychotic and sedative medications may assist in managing short-term crises or comorbid conditions. A substantial number of EUPD patients—up to 90% in some studies—use at least one psychotropic medication, including antipsychotics, antidepressants, mood stabilizers, and sedatives.
Polypharmacy is prevalent among these patients. Most of these medications come with side effects and are often used off-label for EUPD. While some medications may alleviate specific symptoms, they do not alter the overall prognosis of the disorder.
Cannabis-Based Medicine for EUPD (CBM)
Cannabis-based medicines are derived from the cannabis plant and include cannabinoids, the active compounds such as tetrahydrocannabinol (THC) and cannabidiol (CBD). These medicines are used to treat medical conditions and symptoms like pain, anxiety, inflammation, and more.
Several studies are currently exploring the impact of cannabis on mental health. For instance, research published in Frontiers in Psychiatry indicates that marijuana may alleviate depression and enhance sleep quality and overall life satisfaction. These findings support further investigation into cannabis’s effects on various mental health disorders.
Using CBM for Unstable Personality Disorder
A narrative review and case series study in 2022 examined the use of cannabinoids to manage EUPD symptoms in seven patients. Researchers investigated cellular and molecular mechanisms and reviewed the existing evidence for cannabis-based medicinal products (CBMP) as a potential EUPD treatment.
Research Methodology
Participants were diagnosed with EUPD and had tried at least one medication and one form of psychotherapy, with a follow-up at a Zerenia clinic, including patient-reported outcome measures (PROMS).
CBM utilized included dried flower for inhalation (20-60g per month) and oral extracts featuring THC (9-10mg/day) and CBD (40mg/day). The formulations varied from high THC and low CBD to balanced THC and CBD, as well as high CBD and low THC.
Measurement tools included the Clinical Global Impression Improvement (CGI-I) Scale and the Patient’s Global Impression of Change (PGIC) Scale, both assessing improvement based on a 1-7 scale.
Researchers personalized dosing through gradual titration, providing guidelines to increase the dose until satisfactory symptom control was achieved or side effects were noted.
Study Results
At a one-month follow-up, six participants noted improvements, with five rating their change as a six on the PGIC scale. Only one patient, receiving a chemotype 2 oral extract, reported no benefits, suggesting that inhaled THC or higher oral CBD doses may be more effective.
All participants tolerated the treatment well, with no side effects reported, which is crucial for treatment adherence. Younger patients may prefer medical cannabis despite any societal stigma.
Research Hypothesis
Researchers suggest that exogenous cannabinoids may help restore the tonic activation of the endocannabinoid system (ECS) in the central nervous system (CNS). THC activates presynaptic CB1 receptors, and both cannabinoids bind to fatty-acid binding proteins (FABPs), potentially slowing down the degradation of anandamide.
High doses of oral CBD (800 mg/day) and patients treated with chemotype 1 flower indicate increased levels of anandamide in circulation. It remains unclear if this is due to cannabidiol affecting transport or degradation of anandamide or if it interacts with other molecular targets. In contrast, psychiatric drugs typically require 2-3 weeks for initial effects and even longer for patients to achieve remission.
Rapid symptom relief can be essential during an “EUPD crisis,” when distressed individuals may resort to benzodiazepines and other anxiety medications, which can lead to tolerance and dependence.
Explore Affordable Cannabis Online for EUPD or BPD
If you’re looking to purchase cheap cannabis online for medical or recreational purposes, check out our extensive selection of cannabis products at Get Kush Canada with competitive pricing. Dispensaries provide Sativa strains for uplifting effects and Indica strains for relaxation, offering the finest cannabis deals to meet diverse preferences.
Tip: Seek out an online dispensary that features same-day cannabis delivery and mail-order marijuana services. This guarantees fast and discreet delivery, as they utilize Canada Post for secure shipping, complete with tracking numbers.
Managing Behavioral Changes with Bulk Cannabis via Mail-Order Marijuana Service
Cannabinoids effectively manage unstable personality disorders by targeting the ECS to maintain anandamide balance. Patients with EUPD can benefit from purchasing cannabis online or finding affordable products to help alleviate their symptoms.
An online cannabis store offering same-day delivery or mail-order options provides a blend of quality and affordability. Experience exceptional customer service from a friendly team and explore a wide variety of bulk cannabis strains, edibles, concentrates, and oils to enhance your experience. Buy cannabis online at Get Kush Canada.
Frequently Asked Questions
Does cheap marijuana mean poor quality?
No, price is not the only determinant of product quality. You can evaluate quality by examining the product’s physical attributes and personal experience. Some dispensaries offer lower prices through monthly or clearance promotions. If a dispensary’s prices are lower than the industry standard, it may raise quality concerns.
Are there any negative effects of marijuana when managing BPD?
According to the study, participants reported no adverse side effects from marijuana use. This is significant for adherence to medications, as a review of 36 studies indicated that side effects accounted for 28% of patients’ non-adherence to antipsychotics. A negative perception of antipsychotic medication was the second most common reason for intentional non-adherence, at 30.5%.
What is the fastest way to feel the effects of cannabinoids for EUPD?
Smoking, vaping, and dabbing are the quickest methods to experience cannabinoid effects. In the study, participants vaped dried flower. While both smoking and vaping produce similar effects, the distinction lies in inhaling smoke (from smoking) versus vapor (from vaping). Dabbing, which involves using concentrates, also leads to rapid effects.
How frequently can I smoke or vape to manage my symptoms?
The effectiveness of cannabis strains and products varies based on individual preference. In the study, researchers allowed patients to adjust their daily dose (between 0.5 and 2 grams per day) as long as they didn’t exceed the monthly limit. For extracts, patients documented their daily dosage.
Related Articles:
